Clinical Trials Browser

NIH × Dermatofibrosarcoma × Imatinib Mesylate × Clear all

NCT00084630 2013-02-28

Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans

Phase 2 Completed

Fibrosarcoma, Sarcoma, Dermatofibrosarcoma